Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radium 223”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableUnknownNCT02925702
What this trial is testing

PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.

Who this might be right for
Advanced Prostate CancerCastration ResistantRadium 223
Centro Nacional de Investigaciones Oncologicas CARLOS III 161
Not applicableStudy completedNCT04587427
What this trial is testing

Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before

Who this might be right for
Bone Metastatic Castration-resistant Prostate Cancer
Bayer 1,067
Testing effectiveness (Phase 2)Study completedNCT00667199
What this trial is testing

BAY88-8223, Does Response Study in HRPC Patients

Who this might be right for
Hormone Refractory Prostate CancerBone Metastases
Bayer 100
Testing effectiveness (Phase 2)Study completedNCT02507570
What this trial is testing

Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis

Who this might be right for
Prostate Carcinoma Metastatic to the Bone
Carolina Research Professionals, LLC 40
Early research (Phase 1)Study completedNCT02442063
What this trial is testing

Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions

Who this might be right for
NeoplasmsBone Diseases
Bayer 15
Not applicableStudy completedNCT02981797
What this trial is testing

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Who this might be right for
Prostate CancerProstate Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 10
Early research (Phase 1)Study completedNCT03737370
What this trial is testing

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Tufts Medical Center 43
Testing effectiveness (Phase 2)Study completedNCT02390934
What this trial is testing

Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Gustave Roussy, Cancer Campus, Grand Paris 13
Not applicableStudy completedNCT04256993
What this trial is testing

PRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEn

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Bayer 1,434
Testing effectiveness (Phase 2)Active Not RecruitingNCT03344211
What this trial is testing

Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate Cancer
University of Southern California 30
Early research (Phase 1)Ended earlyNCT02429804
What this trial is testing

NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma
Stanford University 4
Large-scale testing (Phase 3)Study completedNCT01618370
What this trial is testing

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer 705
Testing effectiveness (Phase 2)WithdrawnNCT02656563
What this trial is testing

Radium 223 Following Intermittent ADT

Who this might be right for
Prostate Cancer
Canadian Urology Research Consortium
Large-scale testing (Phase 3)UnknownNCT03458559
What this trial is testing

Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

Who this might be right for
Prostate Cancer Metastatic to Bone
Amsterdam UMC, location VUmc 402
Testing effectiveness (Phase 2)Study completedNCT02199197
What this trial is testing

Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Utah 49
Early research (Phase 1)WithdrawnNCT02396368
What this trial is testing

Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate CancerBone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableUnknownNCT03414437
What this trial is testing

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Who this might be right for
Prostate Cancer Metastatic
Carolina Research Professionals, LLC 31
Not applicableNo Longer AvailableNCT01516762
What this trial is testing

Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostatic Neoplasms
Bayer
Testing effectiveness (Phase 2)Active Not RecruitingNCT03361735
What this trial is testing

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
City of Hope Medical Center 25
Not applicableStudy completedNCT02135484
What this trial is testing

Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 27
Load More Results